TruthArchive.ai - Related Video Feed

"You were the driving force behind Operation Warp Speed, these mRNA vaccines that are the gold standard. Now your health secretary is pulling back all the funding for research. He's saying that the risks outweigh the benefits, which puts him at odds with the entire medical community and with you. What is going on? Research on what? Into mRNA vaccines. Well, we're gonna look at that. We're talking about it, and they're doing a very good job. With Operation Warp Speed was, whether you're Republican or Democrat, considered one of the most incredible things ever done in this country. The efficiency, the the way it was done, the distribution, everything about it was has been amazing. But, you know, that was, now a long time ago, and we're on to other things. But we are speaking about it. We have meetings about it tomorrow, actually, tomorrow at 12:00, and we'll determine. We're looking for other answers to other problems, to other sicknesses or diseases, and I think we're doing really well. Like you, mister president."

I am puzzled by Trump's support for mRNA vaccines and Peter Marks at the FDA. Marks, a key figure in Operation Warp Speed, now wants to use the same approach for cancer treatment. He advocates for speeding up drug approvals by easing FDA regulations. Marks controls information flow and defends the vaccine program, despite concerns like myocarditis. He is seen as the gatekeeper for vaccine information.

Robert F. Kennedy Jr. states that HHS, via BARDA, is canceling 22 mRNA vaccine development investments, mostly for flu and COVID. He claims mRNA vaccines don't perform well against viruses infecting the upper respiratory tract because mRNA only codes for a small part of viral proteins, and one mutation can make the vaccine ineffective. Kennedy alleges this drives antigenic shift, where vaccines encourage new mutations, prolonging pandemics as viruses mutate to escape the vaccine's protection. He asserts that HHS, after reviewing science and consulting experts at NIH and FDA, determined mRNA technology poses more risk than benefits for respiratory viruses. According to Kennedy, BARDA is terminating contracts totaling just under $500,000,000 and prioritizing safer, broader vaccine strategies like whole virus vaccines. He clarifies that HHS supports safe, effective vaccines but is moving beyond mRNA's limitations for respiratory viruses.

The speaker believes that halting mRNA vaccine research and development at BARDA is a tragic, non-science-based mistake. They state that mRNA vaccines saved lives, citing estimates that in 2021, unvaccinated individuals were 12 times more likely to be hospitalized and die, and in 2022, six times more likely. The speaker, a member of the FDA vaccine advisory committee, notes initial concerns about potential serious side effects when the vaccine was rolled out to millions, but these did not materialize. While the vaccine can cause rare myocarditis, it is transient and self-resolving, unlike myocarditis caused by the virus itself, which can lead to hospitalization and death. The speaker emphasizes the technology's potential beyond COVID-19, including applications for cancer and gene therapy.

The speaker questions the government's decision to continue with mRNA vaccines despite evidence suggesting they may not be effective for respiratory diseases. They mention the partnership with Moderna to build a manufacturing plant in the UK, capable of producing 250 million vaccines annually. The speaker also highlights Moderna's pipeline of 48 products, including ongoing trials for cytomegalovirus, influenza, and respiratory syncytial virus. They raise concerns about the contradiction between the vaccines' effectiveness and the push for more mRNA vaccines. The speaker wonders if this is a result of deception by big pharma.

Robert F. Kennedy Jr., as HHS Secretary, states that BARDA is canceling 22 mRNA vaccine development investments, primarily for flu and COVID. He claims mRNA vaccines don't perform well against upper respiratory viruses because they only code for a small part of viral proteins, and a single mutation can make them ineffective. Kennedy alleges this drives antigenic shift, where vaccines encourage new mutations, potentially prolonging pandemics. He asserts that millions contracted Omicron despite vaccination, illustrating this risk. HHS, after consulting NIH and FDA experts, has determined mRNA technology poses more risk than benefit for respiratory viruses. The canceled contracts total just under $500 million. HHS will prioritize safer, broader vaccine strategies like whole virus vaccines and novel platforms that don't collapse when viruses mutate. Kennedy states HHS supports safe, effective vaccines but is moving beyond mRNA limitations for respiratory viruses.

US Health Secretary Robert F. Kennedy has reportedly blocked half a billion dollars in funding for respiratory disease vaccine research, canceling over 20 government contracts for mRNA jabs. Kennedy, described as a longtime vaccine skeptic, stated his department concluded the vaccines pose more risk than protection against respiratory illness. Jonathan Ball, Professor of Molecular Virology at the Liverpool School of Tropical Medicine, responded by calling the move an example of misinformation and anti-science. He stated that mRNA vaccines have been incredibly effective, helped bring the COVID pandemic under control, and offer great hope for other infectious diseases.

Over the past few weeks, BARDA reviewed 22 mRNA vaccine development investments and began canceling them. Here's the problem: mRNA only codes for a small part of the viral proteins, usually a single antigen. One mutation and the vaccine becomes ineffective. That's because a single mutation can make mRNA vaccines ineffective. After reviewing the science and consulting top experts at NIH and FDA, HHS has determined that mRNA technology poses more risk than benefits for these respiratory viruses. To replace the troubled mRNA programs, we're prioritizing the development of the safer, broader vaccine strategies like whole virus vaccines and novel platforms that don't collapse when viruses mutate. Let me be absolutely clear: HHS supports safe, effective vaccines for every American who wants them.

The speaker questions the former president about the current health secretary pulling funding for mRNA vaccine research, claiming the risks outweigh the benefits, putting him at odds with the medical community and the former president. The former president states they are going to look into it and are talking about it. He calls Operation Warp Speed one of the most incredible things ever done in the country. He says that was a long time ago, and they are onto other things. He states they are speaking about it and have meetings about it, including one tomorrow at 12:00, to determine next steps. He says they are looking for other answers to other problems, sicknesses, or diseases.

Speaker 0 argues that "Big pharma is just not gonna sit there and go, this is wonderful. Bobby Kennedy, who's an anti vax wingnut, just canceled the most promising technology out there." He cites BARDA actions—"cancellation, descoping of various contracts and solicitations relate to mRNA vaccine development activities"—and says "We reviewed the science, listened to the experts enacted." He calls the "buried lead" that "you have to show the receipts here," warning that "the companies out there that are publicly traded" will pursue "massive lawsuits" and that critics are "a bunch of vaccine wingnuts." He urges HHS/BARDA to present "what we looked at" and "the underlying science" to back their conclusions, which he says are "180 degrees from what people have been spoon fed by the most credentialed class in the country." Speaker 1 adds that "over 3,500 peer reviewed papers" show harms and can be found at react19.org; "continued science comes out showing the harms." We should have done this research before immunization. Pharma will come back "guns blazing." We must "unify" scientists and, in court, "make the case that this was a good decision." He calls the stance an "opening salvo" and predicts the battle "is gonna be massive."

The speakers claim the COVID-19 vaccination program is an ongoing mass experiment that President Trump doesn't want to stop because he is proud of Operation Warp Speed. One speaker says this is tragic because the vaccines are being given to kids. One speaker describes internal fighting and paradoxical actions, such as trying to block the vaccine rollout while simultaneously targeting new variants with updated mRNA vaccines. They assert the vaccines are killing people, referencing autopsy evidence and histopathology. One speaker highlights a leaked video where Trump suggests limiting the vaccine for kids but believes it helps older people. The other speaker refutes this, stating the vaccine kills older people, citing autopsy findings and a BMJ report by the Norwegian Health Authority that found the vaccine likely caused at least 10% and possibly up to 36% of post-vaccination deaths investigated. They claim the CDC reports zero deaths from mRNA vaccines, a claim they dispute based on histopathology slides.

The transcript presents a polarized view on mRNA COVID vaccines. It states: "the US Department of Health and Human Services is slashing a half billion dollars in government funding from mRNA vaccine development." It notes mixed messages: "the FDA is fast tracking possible coronavirus vaccine" and "The mRNA vaccine... has probably saved about three million lives." Personal stories describe injuries: "a week after his vaccination, Joel's health began to rapidly decline," leading to transverse myelitis; Toby and Jessica recount autoimmune-like symptoms and chronic pain. Critics argue that "lipid nanoparticles go everywhere in the body, To the brain, to the bone marrow, to the liver, to the spleen, most importantly to the reproductive organs" and that "the spike protein is the toxic part of this virus that causes clotting, that causes inflammation, that causes myocarditis, that causes brain fog." Robert Malone and others claim "the evidence about the adverse events from the vaccines is unequivocal. It is absolutely overwhelming." The piece highlights advocacy groups and calls for more safety research and support for the vaccine-injured.

Raja Chohan from the National Institute of Health discusses concerns about the NIH's funding of the Wuhan lab and the accelerated approval process for mRNA vaccines like Pfizer and Moderna. He notes that traditional vaccines require multiple approval rounds, unlike the recent ones. Chohan expresses worry about potential long-term effects of the mRNA vaccines, particularly regarding myocarditis. He mentions that guidelines, such as the six-foot social distancing rule, lacked scientific backing. He suggests that having a Democrat in office might be less detrimental for the NIH, hinting at the need for more transparency in discussions about these issues.

Robert F. Kennedy Jr., as HHS secretary, explains that BARDA is canceling 22 mRNA vaccine development investments, primarily for flu and COVID. He claims mRNA vaccines don't perform well against upper respiratory viruses because they only code for a small part of viral proteins, and a single mutation can make them ineffective. This drives antigenic shift, paradoxically encouraging new mutations and prolonging pandemics. HHS has determined that mRNA technology poses more risk than benefits for these viruses. The canceled contracts total just under $500 million. HHS will prioritize safer, broader vaccine strategies like whole virus vaccines and novel platforms that don't collapse when viruses mutate. HHS supports safe, effective vaccines and is moving beyond the limitations of mRNA for respiratory viruses.

"this is a massive win for Secretary Kennedy and basically a silencing of many of the critics." "It's not a ban on mRNA like many people would like to see." "However, it is the wind down of the government investing through BARDA in these technologies." "and their global health investment corporation partner is advised to stop all equity investments in modified RNA technologies." "So follow the money." "When the money isn't there, these are going to fizzle." "This is a bombshell." "The repercussions are going to be felt worldwide." "There will be backlash." "It's not for human use." "This de investment in these 22 projects, it's just the beginning."

Robert F. Kennedy Jr. states that HHS, via BARDA, is canceling 22 mRNA vaccine development investments, mostly for flu and COVID. He claims mRNA vaccines don't perform well against viruses infecting the upper respiratory tract because mRNA only codes for a small part of viral proteins, and one mutation can make the vaccine ineffective. Kennedy alleges this drives antigenic shift, where vaccines encourage mutations and prolong pandemics as viruses mutate to escape the vaccine's protection. HHS has determined that mRNA technology poses more risk than benefits for these respiratory viruses. The canceled contracts total just under $500,000,000. HHS is prioritizing safer, broader vaccine strategies like whole virus vaccines and novel platforms that don't collapse when viruses mutate. HHS supports safe, effective vaccines but is moving beyond the limitations of mRNA for respiratory viruses.

Robert F. Kennedy Jr.: Hi, it's Robert F. Kennedy Jr. here, your HHS secretary. At HHS, we have a division called the Biomedical Advanced Research and Development Authority, or BARDA. BARDA drives some of our most advanced scientific research. It funds developments of vaccines, drugs, diagnostics, and other tools to fight emerging diseases and national health threats. Over the past few weeks, BARDA reviewed 22 mRNA vaccine development investments and began canceling them. Let me explain why. Most of these shots are for flu or COVID, but as the pandemic showed us, mRNA vaccines don't perform well against viruses that infect the upper respiratory tract. Here's the problem: mRNA only codes for a small part of the viral proteins, usually a single antigen. One mutation and the vaccine becomes ineffective. This dynamic drives a phenomena called antigenic shift, meaning that the vaccine paradoxically encourages new mutations and can actually prolong pandemics as the virus constantly mutates to escape the protective effects of the vaccine. Millions of people, maybe even you or someone you know, caught the omicron variant despite being vaccinated. That's because a single mutation can make mRNA vaccines ineffective. The same risk applies to flu. After reviewing the science and consulting top experts at NIH and FDA, HHS has determined that mRNA technology poses more risk than benefits for these respiratory viruses. That's why after extensive review, BARDA has begun the process of terminating these 22 contracts totaling just under $500,000,000 To replace the troubled mRNA programs, we're prioritizing the development of the safer, broader vaccine strategies, like whole virus vaccines and novel platforms that don't collapse when viruses mutate. Let me be absolutely clear: HHS supports safe, effective vaccines for every American who wants them. That's why we're moving beyond the limitations of mRNA for respiratory viruses and investing in better solutions. Thank you. Produced by the U. S. Department of Health and Human Services.

"And, you know, we're not here to judge anyone that did take a shot." "And in fact, what we need to focus on now is government funding, NIH funding for those who did and are still suffering." "There are a lot of people left in the wake of this program." "However, I think these bold moves give us basically fodder for the cannon to continue to fire and say, look, we will work on better science, better technology, but let's not forget those who were harmed by this." "And we need to focus on better technologies, not gene therapies that go to every cell in the body, not gene therapies for respiratory viruses." "As the secretary said, look, we're for good science. We're not trying to pull everybody's vaccine away from them, but we're not gonna allow them to take unsafe ones."

Robert F. Kennedy Jr. states that HHS, via BARDA, is canceling 22 mRNA vaccine development investments, mostly for flu and COVID, because mRNA vaccines don't perform well against upper respiratory viruses. mRNA only codes for a small part of viral proteins, and one mutation can make the vaccine ineffective, driving antigenic shift, which encourages new mutations and prolongs pandemics. Millions caught Omicron despite being vaccinated, demonstrating this. HHS determined mRNA technology poses more risk than benefit for respiratory viruses after consulting experts at NIH and FDA. BARDA is terminating contracts totaling just under $500 million. HHS is prioritizing safer, broader vaccine strategies like whole virus vaccines and novel platforms that don't collapse when viruses mutate. HHS supports safe, effective vaccines but is moving beyond the limitations of mRNA for respiratory viruses.

The US Health Department intends to cancel contracts and cut funding for some vaccine development projects, including those targeting COVID-19. Health Secretary Robert F. Kennedy Jr. announced that $500 million in funding would be halted for 22 projects, many led by major drug makers like Pfizer and Moderna. These projects use mRNA technology. While mRNA vaccines are credited with slowing the 2020 coronavirus pandemic, Kennedy stated he wants the department to invest in "better solutions," but did not elaborate on what those solutions would be. The Department of Health and Human Services is pulling the funding and Kennedy is calling on the department to move away from mRNA vaccines.

The US Health Department intends to cancel contracts and cut funding for some vaccine development projects, including those targeting COVID-19. Health Secretary Robert F. Kennedy Jr. announced the halt of $500 million in funding for 22 projects, many led by major drug makers like Pfizer and Moderna. These projects utilize mRNA technology. While mRNA vaccines are credited with slowing the 2020 coronavirus pandemic, Kennedy stated he wants the department to invest in "better solutions," though he did not specify what those solutions would be.

The speaker states that while messenger RNA (mRNA) can be used to produce missing proteins like insulin, using mRNA for vaccines is a failed and dangerous concept. They criticize the US government for not being honest about their involvement in mRNA research, specifically the Adept p three program, which aimed to use mRNA to end pandemics within 60 days.

US Health Secretary Robert F. Kennedy has blocked $500 million in funding for respiratory disease vaccine research, canceling over 20 government contracts for mRNA jabs. Kennedy, a long-time vaccine skeptic, stated his department concluded the vaccines pose more risk than protection against respiratory illness. Professor Jonathan Ball, a Molecular Virology expert, responded by calling the move an example of misinformation and anti-science. He stated that mRNA vaccines have been incredibly effective, helped bring the COVID pandemic under control, and offer great hope for other infectious diseases.

MRNA vaccines were hailed as medical breakthroughs in the fight against COVID. Now the US Department of Health and Human Services is slashing a half billion dollars in government funding from mRNA vaccine development. The current vaccines are not infection blocking. When new variants come up, you lose protection, and they have very short duration. There was never a vaccine made with mRNA. Lipid nanoparticles go everywhere in the body, to the brain, to the bone marrow, to the liver, to the spleen, most importantly to the reproductive organs. I regret it every single day that I walked into my local pharmacy to get that shot in my arm. The spike protein directly causes blood clotting and is found in the middle of large blood clots. This vaccine, the mRNA vaccine, has probably saved about three million lives.

- "After reviewing the science and consulting top experts at NIH and FDA, HHS has determined that mRNA technology poses more risk than benefits for these respiratory viruses." - "BARDA has begun the process of terminating these 22 contracts totaling just under $500,000,000 To replace the troubled mRNA programs, we're prioritizing the development of safer, broader vaccine strategies, like whole virus vaccines and novel platforms that don't collapse when viruses mutate." - "I'm still waiting for Robert Kennedy Jr. To say that we're going to wipe out mandates and everyone will have a choice, but this is a great step in the right direction." - "Half a billion dollars, 22 projects in the pipeline for mRNA vaccine technology." - "KFF Foundation did a survey on really what Americans are still going to want this vaccine going into the fall, the COVID vaccine."